WT
EW icon

Wilmington Trust’s Edwards Lifesciences EW Stock Holding History

Wilmington Trust’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$329K Sell
22,980
-1,326
-5% -$18K 0.01% 587
2014
Q1 		$300K Buy
+24,306
New +$280K 0.01% 594

Other funds holding EW

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wilmington Trust's EW Position: Q2 2014 in Review

Wilmington Trust reduced its Edwards Lifesciences (EW) stake by 5.5% in Q2 2014, selling an estimated $18K and leaving 22,980 shares worth $329K. The position accounts for 0.01% of the portfolio, ranked #587.

Wilmington Trust first reported a position in EW in Q1 2014 and has held it in 2 quarters since. 429 funds tracked by Wall St. Rank hold EW as of Q2 2014.

  • Wilmington Trust held 22,980 shares of Edwards Lifesciences worth $329K as of Q2 2014.
  • Wilmington Trust sold 1,326 Edwards Lifesciences shares in Q2 2014, an estimated $18K.
  • Edwards Lifesciences made up 0.01% of Wilmington Trust's portfolio in Q2 2014, its #587 holding.
  • Wilmington Trust first reported a position in Edwards Lifesciences in Q1 2014 and has held it in 2 quarters since.
  • 429 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2014.

Based on Wilmington Trust's 13F filing for Q2 2014, filed 13 Aug 2014.